
Jae Park, MD
Leukemia Specialist & Cellular Therapist
Titles
Chief, Cellular Therapy Service
Clinical Expertise
Adult Acute and Chronic Leukemias; Lymphoproliferative Disorders; Cellular Immunotherapy
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Park accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Contact and Location
- 646-608-3743 Office Phone
- Speaks English and Korean

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MD, Johns Hopkins School of Medicine
Residencies
Internal Medicine - Massachusetts General Hospital
Fellowships
Medical Hematology/Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
Internal Medicine; Medical Oncology
I am a hematologist-oncologist specializing in the care of patients with leukemia. Along with other colleagues on the Leukemia Service at Memorial Sloan Kettering Cancer Center, I am dedicated to providing the best possible care by treating each patient as if he or she were a member of my own family.
Read more
As an active translational investigator, I have spent time both in the laboratory and in clinics to bring new and innovative treatments to patients with leukemia. I am particularly interested in developing more-effective and personalized therapies for patients with acute and chronic lymphoid leukemia, and am the lead investigator of a clinical trial using genetically modified T cells to treat patients with chronic lymphocytic leukemia (CLL). I am also a co-principal investigator on several other clinical trials in patients with acute lymphoblastic leukemia (ALL) and CLL.
My ultimate goal as a physician is to develop new and potentially curative therapies for patients with leukemia and to provide compassionate and individualized care to address each patient’s unique needs.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Park
- A Phase 1 Study of a New CAR T Cell Therapy for People With Recurrent or Persistent Large B-Cell Lymphoma
- A Phase I Study of FT819 CAR T-Cell Therapy in People with B-Cell Cancers
- A Phase IB/II Study of AUTO1 CAR T-Cell Therapy in People with Recurrent or Persistent B-Cell Acute Lymphoblastic Leukemia: The FELIX Trial
- A Phase IB/II Study of Venetoclax plus Liposomal Vincristine in Patients with Recurrent or Persistent T-Cell or B-Cell Acute Lymphoblastic Leukemia
Read more
- A Phase II/III Study of Calaspargase Pegol for Adults with Newly Diagnosed Philadelphia-negative Acute Lymphoblastic Leukemia
- A Study of Venetoclax plus Chemotherapy for Newly Diagnosed Acute Lymphoblastic Leukemia
- Clinical Trials Co-Investigated by Dr. Park
- A Phase I Study of Inotuzumab Ozogamicin in People with Acute Lymphocytic Leukemia Who Have Received a Stem Cell Transplant
- A Phase I Study of PSB202 in People with Recurrent or Persistent Indolent B-Cell Lymphoma
- A Phase II Study of Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- A Phase II Study of Venetoclax and Obinutuzumab as Initial Therapy for Chronic Lymphocytic Leukemia

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Read more
Patient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Jae Park discloses the following relationships and financial interests:
-
Affyimmune Therapeutics, Inc.
Provision of Services -
Allogene Therapeutics
Provision of Services -
Amgen
Provision of Services -
Artiva Biotherapeutics, Inc.
Provision of Services -
Autolus Therapeutics
Provision of Services -
BeiGene, Ltd.
Provision of Services
-
Bristol-Myers Squibb
Provision of Services -
Curocell Inc.
Provision of Services -
Kite Pharmaceuticals
Provision of Services -
Minerva Biotechnologies
Provision of Services -
Pfizer, Inc.
Provision of Services -
Servier
Provision of Services
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].